TRUALT Share Price | TruAlt Bioenergy Ltd Stock Analysis & Recommendation

Q: Are TruAlt Bioenergy Ltd latest results good or bad?

TruAlt Bioenergy Ltd's latest results present a mixed picture. On one hand, the company achieved a remarkable quarter-on-quarter revenue growth of 520.96%, reaching ₹713.24 crores, and returned to profitability with a net profit of ₹69.33 crores, marking a significant increase of 282.74% compared to the previous quarter. This indicates strong operational momentum and recovery in demand.However, the profitability metrics reveal concerning trends. The operating margin has compressed significantly from 30.01% in the same quarter last year to 18.79% this year, and the profit after tax (PAT) margin has also declined from 18.11% to 9.70%. This suggests that while the company is generating more revenue, it is struggling to maintain profitability due to rising costs or operational inefficiencies.Additionally, the year-on-year comparison shows a decline in net profit by 7.79%, which raises concerns about the sustainability of the recent growth. The company's elevated debt levels and weak interest coverage ratio further complicate its financial health.In summary, while the revenue growth is impressive and indicates a recovery, the significant margin compression and declining profitability metrics suggest that the results are not entirely favorable. Investors should be cautious and monitor how the company addresses these challenges moving forward.

Q: Why is TruAlt Bioenergy Ltd falling/rising?

As of 04-Mar, TruAlt Bioenergy Ltd's stock price is falling, currently at 376.35, which reflects a decrease of 1.65 (-0.44%). The stock has been on a downward trend, having lost 8.43% over the last five days and opened today with a loss of 4.5%. It also reached an intraday low of Rs 361, indicating significant selling pressure.The stock's performance has been underwhelming compared to the benchmark Sensex, with a 1-week decline of 7.73% against the Sensex's 3.84%. Over the past month, the stock has decreased by 1.63%, while the Sensex fell by 5.61%. Year-to-date, TruAlt Bioenergy has dropped 6.90%, slightly better than the Sensex's 7.16% decline.Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a bearish trend. Although there has been a rise in delivery volume, increasing by 53.38% against the 5-day average, this does not seem to be enough to counteract the overall negative sentiment surrounding the stock.The company faces challenges such as high debt levels, with a debt-to-equity ratio averaging 0 times, and has reported losses leading to a negative return on capital employed (ROCE). Furthermore, institutional investors have reduced their stakes by 0.9% in the previous quarter, which may indicate a lack of confidence in the company's long-term fundamentals. Overall, these factors contribute to the stock's decline.

Q: Should I buy, sell or hold TruAlt Bioenergy Ltd?

Based on the current situation of TruAlt Bioenergy Ltd, it would be advisable to consider a strong sell recommendation. The company is facing significant challenges, including a high debt level with a debt-to-equity ratio of zero, which indicates a concerning financial structure. Additionally, the company has reported losses, leading to a negative return on capital employed (ROCE).The recent performance is also troubling, with a decline in profit after tax over the last six months, showing a decrease of 44.47%. Furthermore, there has been a reduction in institutional investor participation, which is often a red flag as these investors typically have the resources to assess company fundamentals more effectively than retail investors.TruAlt Bioenergy Ltd has underperformed the market over the past year, generating no return, despite a notable increase in profits. Given these factors, it would be prudent to sell your holdings in the company and look for more stable investment opportunities.

Technical Trend Update: TruAlt Bioenergy witnessed a change in Technical Grade on 04 Mar 2026. Click here to discover latest technical change!

Mojo Score Change: TruAlt Bioenergy has changed its score on 04 Mar 2026. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

91.48 k (-30.04%) Volume

Shareholding (Dec 2025)

FII

0.93%

Held by 14 FIIs

DII

2.34%

Held by 6 DIIs

Promoter

70.55%

Are TruAlt Bioenergy Ltd latest results good or bad?

04-Feb-2026

TruAlt Bioenergy Ltd's latest results show impressive revenue growth of 520.96% and a return to profitability, but declining operating and profit margins, along with a year-on-year net profit drop of 7.79%, raise concerns about sustainability. Investors should be cautious due to these mixed signals and the company's elevated debt levels.

View full answer

Why is TruAlt Bioenergy Ltd falling/rising?

05-Mar-2026

As of 04-Mar, TruAlt Bioenergy Ltd's stock price is at 376.35, reflecting a decline of 1.65 (-0.44%) and a significant downward trend with an 8.43% loss over the past five days. The stock is underperforming compared to the Sensex and is trading below its moving averages, indicating a bearish outlook amid high debt levels and reduced institutional confidence.

View full answer

Which are the latest news on TruAlt Bioenergy?

05-Mar-2026

TruAlt Bioenergy Downgraded to Strong Sell Amid Technical Weakness and Flat Financials
TruAlt Bioenergy Ltd Faces Mildly Bearish Momentum Amid Technical Downgrade

Should I buy, sell or hold TruAlt Bioenergy Ltd?

05-Mar-2026

Compare TruAlt Bioenergy with Similar Stocks

Gujarat Alkalies Grauer & Weil Chemplast Sanmar

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

High Debt company with Weak Long Term Fundamental Strength

High Debt Company with a Debt to Equity ratio (avg) at 0 times
The company has reported losses. Due to this company has reported negative ROCE

Flat results in Dec 25

Falling Participation by Institutional Investors

Underperformed the market in the last 1 year

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Commodity Chemicals

Market cap

INR 3,227 Cr (Small Cap)

P/E

23.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.89

Return on Equity

10.11%

Price to Book

2.32

Revenue and Profits:

Net Sales:

713 Cr

(Quarterly Results - Dec 2025)

Net Profit:

69 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-11.51%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

TruAlt Bioenergy for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

TruAlt Bioenergy Downgraded to Strong Sell Amid Technical Weakness and Flat Financials

TruAlt Bioenergy Ltd, a player in the Commodity Chemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 4 March 2026. This shift reflects deteriorating technical indicators, flat financial performance, and waning institutional interest, signalling caution for investors amid challenging market conditions.

Read full news article

TruAlt Bioenergy Ltd Faces Mildly Bearish Momentum Amid Technical Downgrade

TruAlt Bioenergy Ltd, a player in the Commodity Chemicals sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish outlook. Recent technical indicators, including MACD, RSI, and moving averages, suggest increasing downside pressure, prompting a downgrade in its MarketsMOJO grade to Strong Sell as of 4 March 2026.

Read full news article

TruAlt Bioenergy Ltd Faces Technical Momentum Shift Amid Market Pressure

TruAlt Bioenergy Ltd, a player in the Commodity Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a challenging market environment. The stock’s recent price action, combined with key technical indicators, signals a sideways trend with bearish undertones, prompting a downgrade in its investment grade and raising concerns among investors.

Read full news article

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

13-Feb-2026 | Source : BSE

Transcript of the Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter and nine months ended December 31 2025

Monitoring Agency Report

10-Feb-2026 | Source : BSE

Trualt Bioenergy Limited has informed the exchange about Monitoring Agency Report for the quarter ended December 31 2025.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

09-Feb-2026 | Source : BSE

Please find enclosed the audio recording link of Investors/ analysts earning call held today i.e. February 9 2026.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

1.28

Debt to EBITDA (avg)

5.14

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.64

Tax Ratio

7.58%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

8.20%

ROCE (avg)

8.87%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.29

EV to EBIT

19.01

EV to EBITDA

14.88

EV to Capital Employed

1.69

EV to Sales

2.35

PEG Ratio

Dividend Yield

ROCE (Latest)

8.87%

ROE (Latest)

10.11%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Bearish

KST

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 5 Schemes (4.35%)

FIIs

Held by 14 FIIs (0.93%)

Promoter with highest holding

Vijaykumar Nirani (17.88%)

Highest Public shareholder

Rakeshkumar Viththalbhai Patel (3.82%)

Individual Investors Holdings

14.43%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 572.88% vs -64.45% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 254.43% vs -1,42,600.00% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "703.02",
          "val2": "104.48",
          "chgp": "572.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "129.05",
          "val2": "-11.79",
          "chgp": "1,194.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "39.65",
          "val2": "38.01",
          "chgp": "4.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "66.02",
          "val2": "-42.75",
          "chgp": "254.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.36%",
          "val2": "-11.28%",
          "chgp": "29.64%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "398.41",
          "val2": "573.53",
          "chgp": "-30.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.10",
          "val2": "27.23",
          "chgp": "-15.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "75.26",
          "val2": "67.15",
          "chgp": "12.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-42.72",
          "val2": "-41.99",
          "chgp": "-1.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.80%",
          "val2": "4.75%",
          "chgp": "1.05%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,101.43",
          "val2": "980.84",
          "chgp": "12.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "152.15",
          "val2": "146.27",
          "chgp": "4.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "114.91",
          "val2": "102.57",
          "chgp": "12.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "23.30",
          "val2": "30.39",
          "chgp": "-23.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.81%",
          "val2": "14.91%",
          "chgp": "-1.10%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,880.12",
          "val2": "1,223.40",
          "chgp": "53.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "297.20",
          "val2": "188.08",
          "chgp": "58.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "141.04",
          "val2": "143.08",
          "chgp": "-1.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "140.62",
          "val2": "31.81",
          "chgp": "342.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.81%",
          "val2": "15.37%",
          "chgp": "0.44%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

703.02

104.48

572.88%

Operating Profit (PBDIT) excl Other Income

129.05

-11.79

1,194.57%

Interest

39.65

38.01

4.31%

Exceptional Items

0.00

Standalone Net Profit

66.02

-42.75

254.43%

Operating Profit Margin (Excl OI)

18.36%

-11.28%

29.64%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 572.88% vs -64.45% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 254.43% vs -1,42,600.00% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

398.41

573.53

-30.53%

Operating Profit (PBDIT) excl Other Income

23.10

27.23

-15.17%

Interest

75.26

67.15

12.08%

Exceptional Items

0.00

Standalone Net Profit

-42.72

-41.99

-1.74%

Operating Profit Margin (Excl OI)

5.80%

4.75%

1.05%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,101.43

980.84

12.29%

Operating Profit (PBDIT) excl Other Income

152.15

146.27

4.02%

Interest

114.91

102.57

12.03%

Exceptional Items

0.00

Standalone Net Profit

23.30

30.39

-23.33%

Operating Profit Margin (Excl OI)

13.81%

14.91%

-1.10%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

1,880.12

1,223.40

53.68%

Operating Profit (PBDIT) excl Other Income

297.20

188.08

58.02%

Interest

141.04

143.08

-1.43%

Exceptional Items

0.00

Standalone Net Profit

140.62

31.81

342.06%

Operating Profit Margin (Excl OI)

15.81%

15.37%

0.44%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About TruAlt Bioenergy Ltd

TruAlt Bioenergy Ltd

Small Cap

Commodity Chemicals

No Details Available.

Company Coordinates

No Company Details Available